Higher IGFBP-2 levels are linked to a favorable metabolic profile, characterized by reduced visceral fat accumulation and a decreased risk of obesity and insulin resistance [14,24,25]. The gene discussed is IGFBP2; the disease is obesity due to melanocortin 4 receptor deficiency.